Vicarious Surgical (RBOTW) Long-Term Debt Repayments (2022 - 2023)

Vicarious Surgical (RBOTW) reported Long-Term Debt Repayments of $4000.0 for Q2 2023, down 97.33% year-over-year from $150000.0 in Q2 2022, and down 66.67% quarter-over-quarter from $12000.0 in Q1 2023.

Vicarious Surgical (RBOTW) Long-Term Debt Repayments (2022 - 2023) Analysis & Trends

Vicarious Surgical (RBOTW) has 2 years of Long-Term Debt Repayments data on file, last reported at $4000.0 in Q2 2023.

  • Long-Term Debt Repayments for Q2 2023 came in at $4000.0, down 97.33% year-over-year; the trailing twelve-month figure through Dec 2023 was $16000.0 (down 98.81% YoY), and the FY2023 annual result was $16000.0, down 98.81% from the prior year.
  • Long-Term Debt Repayments slipped to $4000.0 in Q2 2023 per RBOTW's latest filing, from $12000.0 in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $900000.0 in Q4 2022 and troughed at $4000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.42 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 1.00 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Vicarious Surgical - - - -

Historic Data

Download Data
DateValue
Jun 30, 2023 4,000.00
Jun 30, 2023 4,000.00
Mar 31, 2023 12,000.00
Mar 31, 2023 12,000.00
Dec 31, 2022 900,000.00
Dec 31, 2022 900,000.00
Sep 30, 2022 150,000.00
Sep 30, 2022 150,000.00
Jun 30, 2022 150,000.00
Jun 30, 2022 150,000.00
Mar 31, 2022 150,000.00
Mar 31, 2022 150,000.00